Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
The Australia story: Current status and future challenges for the clinical applications of psychedelics.British journal of pharmacology · 2026-07-01Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitaloprambioRxiv · 2026-06-26Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation TheorembioRxiv · 2026-06-16Exploring new avenues: Psychedelic-assisted therapy for young people.British journal of clinical pharmacology · 2026-05-08An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialmedRxiv · 2025-03-21Serotonergic psychedelics for depression: A comprehensive overview.International review of neurobiology · 2025-01-01Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.Frontiers in psychology · 2025-01-01Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-07Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.Journal of psychopharmacology (Oxford, England) · 2024-05-01Effects of DMT on mental health outcomes in healthy volunteers.Scientific reports · 2024-02-07Psychedelics and sexual functioning: a mixed-methods study.Scientific reports · 2024-02-07Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.Psychological medicine · 2024-01-01Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.Psychological medicine · 2024-01-01Psilocybin and Other Classic Psychedelics in Depression.Current topics in behavioral neurosciences · 2024-01-01Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.European addiction research · 2024-01-01Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model.Psychological medicine · 2023-12-01Neuroimaging in psychedelic drug development: past, present, and future.Molecular psychiatry · 2023-09-01Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.Psychiatry research · 2023-09-01A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.Journal of psychopharmacology (Oxford, England) · 2023-07-01Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depressionmedRxiv · 2023-06-03Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01Mescaline: The forgotten psychedelic.Neuropharmacology · 2023-01-01Body mass index (BMI) does not predict responses to psilocybin.Journal of psychopharmacology (Oxford, England) · 2023-01-01Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.Nature communications · 2022-10-03Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych open · 2022-09-06Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.Journal of psychopharmacology (Oxford, England) · 2022-08-01Brain dynamics predictive of response to psilocybin for treatment-resistant depressionbioRxiv · 2022-07-04Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.Journal of psychopharmacology (Oxford, England) · 2022-03-01Increased low-frequency brain responses to music after psilocybin therapy for depressionbioRxiv · 2022-02-15LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theorybioRxiv · 2021-05-17Trial of Psilocybin versus Escitalopram for Depression.The New England journal of medicine · 2021-04-15Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.Acta psychiatrica Scandinavica · 2021-02-01Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in psychiatry · 2021-01-01Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2020-02-01Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017Drug Science Policy and Law · 2020-01-01Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.NeuroImage · 2019-10-01Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.Acta neuropsychiatrica · 2019-08-01Psychiatry & the psychedelic drugs. Past, present & future.Neuropharmacology · 2018-11-01Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.Neuropharmacology · 2018-11-01Effects of psilocybin therapy on personality structure.Acta psychiatrica Scandinavica · 2018-11-01Altered trajectories in the dynamical repertoire of functional network states under psilocybinbioRxiv · 2018-07-25Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.Scientific reports · 2018-05-29Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.Journal of affective disorders · 2018-04-01Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.Psychopharmacology · 2018-02-01Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2018-02-01Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific reports · 2017-10-13Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.Frontiers in pharmacology · 2017-01-01Question-based Drug Development for psilocybin - Authors' reply.The lancet. Psychiatry · 2016-09-01Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The lancet. Psychiatry · 2016-07-01Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.Human brain mapping · 2015-08-01A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.Current drug abuse reviews · 2014-01-01The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.Frontiers in human neuroscience · 2014-01-01Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia bulletin · 2013-11-01Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.Journal of psychopharmacology (Oxford, England) · 2013-09-01Experienced drug users assess the relative harms and benefits of drugs: a web-based survey.Journal of psychoactive drugs · 2013-01-01Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British journal of psychiatry: the journal of mental science · 2012-03-01Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences of the United States of America · 2012-02-07The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.Journal of psychopharmacology (Oxford, England) · 2011-11-01